| # | Drug | Count |
|---|---|---|
| 0 | ONABOTULINUMTOXINA | 16 |
| 1 | ASPIRIN | 12 |
| 2 | ASPIRIN 325 MG | 12 |
| 3 | ASPIRIN 81 MG | 12 |
| 4 | AMLODIPINE | 10 |
| 5 | ERGOCALCIFEROL | 10 |
| 6 | ACETAMINOPHEN | 9 |
| 7 | BIMATOPROST | 9 |
| 8 | BOTULINUM TOXIN TYPE A | 8 |
| 9 | LEVOTHYROXINE SODIUM | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE | 1 | 0.0169 |
| 1 | PENPULIMAB | 1 | 0.0102 |
| 2 | HYPOCHLOROUS ACID | 1 | 0.0093 |
| 3 | TETRACAINE | 2 | 0.0051 |
| 4 | ASPIRIN AND DIPYRIDAMOLE | 1 | 0.0041 |
| 5 | TROPICAMIDE | 5 | 0.0031 |
| 6 | LOTEPREDNOL ETABONATE AND TOBRAMYCIN | 1 | 0.0025 |
| 7 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 1 | 0.0021 |
| 8 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | 2 | 0.0018 |
| 9 | FLUOCINOLONE ACETONIDE, HYDROQUINONE, AND TRETINOIN | 1 | 0.0018 |
| # | Drug class | Count |
|---|---|---|
| 0 | Acetylcholine Release Inhibitor [EPC] | 28 |
| 1 | Neuromuscular Blocker [EPC] | 28 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 3 | Corticosteroid [EPC] | 14 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 13 |
| 5 | Calcium Channel Blocker [EPC] | 10 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 10 |
| 7 | Prostaglandin Analog [EPC] | 10 |
| 8 | Vitamin C [EPC] | 10 |
| 9 | GLP-1 Receptor Agonist [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 1 | alpha-1 Adrenergic Agonist [EPC] | 4 | 0.0009 |
| 2 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0009 |
| 3 | Plasma Volume Expander [EPC] | 2 | 0.0006 |
| 4 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 5 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 6 | Semifluorinated Alkane [EPC] | 1 | 0.0004 |
| 7 | Anticholinergic [EPC] | 6 | 0.0004 |
| 8 | Thyroid Hormone Synthesis Inhibitor [EPC] | 3 | 0.0003 |
| 9 | Acetylcholine Release Inhibitor [EPC] | 28 | 0.0003 |